-DigiTimes
Software Error Prompts Zimmer Biomet To Recall Rosa One Robotic Neurosurgery Platform
Zimmer Biomet Holdings Inc (NYSE: ZBH) is facing a Class I recall of its Rosa One Brain platform.
Related Posts
Homebuilders Are Throwing Money At Buyers At A Furious Pace Just To Close A Sale, Data Finds
Homebuilders are increasing incentives just as they did before the COVID-19 pandemic to entice potential buyers of newly constructed homes amid slowing sales.
These factors include rising mortgage rates, increased pricing and shifting consumer perception.
The Daily Biotech Pulse: Moderna Gains On Vaccine News, Novartis Reports Q3 Beat, Adcom Reviews Authorization Of Pfizer-BioNTech’s Vaccine For Children
Here's a roundup of top developments in the biotech space over the last 24 hours: